Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-03-22
11:13 am
Sale
13DSesen Bio, Inc.
SESN
HealthCap VII L.P.3,398,248
8.4%
-181,363decrease
(-5.07%)
View
2023-03-09
10:33 am
Purchase
13DSesen Bio, Inc.
SESN
HealthCap VII L.P.3,579,611
8.9%
3,579,611increase
(New Position)
View
2023-03-06
4:06 pm
Unchanged
13DFusion Pharmaceuticals Inc.
FUSN
HealthCap VII L.P.3,807,247
6.1%
0
(Unchanged)
View
2022-11-15
5:08 pm
Unchanged
13DAprea Therapeutics, Inc.
APRE
HealthCap VII L.P.2,366,104
4.5%
0
(Unchanged)
View
2022-06-30
4:34 pm
Unchanged
13DAprea Therapeutics, Inc.
APRE
HealthCap VII L.P.2,366,104
10.1%
0
(Unchanged)
View
2021-10-15
4:50 pm
Unchanged
13DAprea Therapeutics, Inc.
APRE
HealthCap VII L.P.2,366,104
11.2%
0
(Unchanged)
View
2020-07-10
5:00 pm
Purchase
13DFusion Pharmaceuticals Inc.
FUSN
HealthCap VII L.P.3,807,247
9.1%
3,807,247increase
(New Position)
View
2019-10-18
09:22 am
Purchase
13DAprea Therapeutics, Inc.
APRE
HealthCap VII L.P.2,366,104
11.9%
2,366,104increase
(New Position)
View